Cargando…
Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the American Academy of Dermatology, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608757/ https://www.ncbi.nlm.nih.gov/pubmed/34826538 http://dx.doi.org/10.1016/j.jaad.2021.11.025 |
| _version_ | 1784602797056983040 |
|---|---|
| author | Birabaharan, Morgan Kaelber, David C. Karris, Maile Y. |
| author_facet | Birabaharan, Morgan Kaelber, David C. Karris, Maile Y. |
| author_sort | Birabaharan, Morgan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8608757 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | by the American Academy of Dermatology, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86087572021-11-23 Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study Birabaharan, Morgan Kaelber, David C. Karris, Maile Y. J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2022-09 2021-11-23 /pmc/articles/PMC8608757/ /pubmed/34826538 http://dx.doi.org/10.1016/j.jaad.2021.11.025 Text en © 2021 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Research Letter Birabaharan, Morgan Kaelber, David C. Karris, Maile Y. Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study |
| title | Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study |
| title_full | Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study |
| title_fullStr | Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study |
| title_full_unstemmed | Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study |
| title_short | Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study |
| title_sort | risk of herpes zoster reactivation after messenger rna covid-19 vaccination: a cohort study |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608757/ https://www.ncbi.nlm.nih.gov/pubmed/34826538 http://dx.doi.org/10.1016/j.jaad.2021.11.025 |
| work_keys_str_mv | AT birabaharanmorgan riskofherpeszosterreactivationaftermessengerrnacovid19vaccinationacohortstudy AT kaelberdavidc riskofherpeszosterreactivationaftermessengerrnacovid19vaccinationacohortstudy AT karrismailey riskofherpeszosterreactivationaftermessengerrnacovid19vaccinationacohortstudy |